Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Syros Pharmaceuticals
(NQ:
SYRS
)
0.2593
-0.0158 (-5.74%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Syros Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Syros Announces Clinical Updates and 2023 Strategic Priorities
January 09, 2023
From
Syros Pharmaceuticals
Via
Business Wire
Analyst Expectations for Syros Pharmaceuticals's Future
January 05, 2023
Via
Benzinga
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 23, 2022
From
Syros Pharmaceuticals
Via
Business Wire
Syros Pharmaceuticals's Return On Capital Employed Overview
December 23, 2022
Via
Benzinga
Syros Pharmaceuticals Announces Publication in Blood Advances Demonstrating the Potential of Tamibarotene in Patients with RARA Gene Overexpression, Supporting Ongoing Clinical Development in AML and MDS
December 12, 2022
From
Syros Pharmaceuticals
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
October 20, 2022
Thursday saw 177 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
December 20, 2022
On Tuesday, 298 companies achieved new lows for the year.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
December 19, 2022
On Monday, 297 companies reached new 52-week lows.
Via
Benzinga
Syros Presents Safety Lead-in Data from SELECT-AML-1 Trial Evaluating Tamibarotene in Combination with Venetoclax and Azacitidine and Announces Plans to Initiate Randomized Portion of Phase 2 Trial
December 10, 2022
From
Syros Pharmaceuticals
Via
Business Wire
Syros to Host Virtual Event to Discuss Initial SELECT-AML-1 Data and Unmet Need in Newly Diagnosed Unfit Acute Myeloid Leukemia on December 10
December 05, 2022
From
Syros Pharmaceuticals
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 23, 2022
Via
Benzinga
Syros to Participate at Piper Sandler 34th Annual Healthcare Conference
November 22, 2022
From
Syros Pharmaceuticals
Via
Business Wire
Syros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
November 14, 2022
From
Syros Pharmaceuticals
Via
Business Wire
Earnings Scheduled For November 14, 2022
November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Via
Benzinga
Syros to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022
November 07, 2022
From
Syros Pharmaceuticals
Via
Business Wire
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 04, 2022
From
Syros Pharmaceuticals
Via
Business Wire
Syros Pharmaceuticals to Present Initial Data from SELECT-AML-1 Phase 2 Trial at 64th ASH Annual Meeting
November 03, 2022
From
Syros Pharmaceuticals
Via
Business Wire
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 05, 2022
From
Syros Pharmaceuticals
Via
Business Wire
Why Super Micro Computer Shares Jumped Over 10%; Here Are 73 Biggest Movers From Yesterday
October 21, 2022
Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares climbed 107.3% to close at $0.4138 on Thursday after the company announced its NextFintech division received commitment for a $15 million...
Via
Benzinga
Looking Into Syros Pharmaceuticals's Recent Short Interest
October 05, 2022
Syros Pharmaceuticals's (NASDAQ:SYRS) short percent of float has fallen 48.18% since its last report. The company recently reported that it has 775 thousand shares sold short, which is 4.12% of all...
Via
Benzinga
GLSI, APRN: The Top 5 Short Squeeze Stocks to Watch This Week
October 03, 2022
Investors are still interested in short squeeze stocks lately and we've got them covered with the ones to watch this week!
Via
InvestorPlace
Grenwich LilfeSciences, Blue Apron And 3 More Short Squeeze Candidates That May Soar
October 03, 2022
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates for the week...
Via
Benzinga
10 Short Squeeze Candidates That May Soar: Minerva Neurosciences, FaZe, Getty Images And More
September 26, 2022
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
September 20, 2022
Good morning, investor! It's time to start the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!
Via
InvestorPlace
Why O2Micro International Is Trading Higher By 7%; Here Are 25 Stocks Moving Premarket
September 20, 2022
Gainers
Via
Benzinga
Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday
September 20, 2022
Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday.
Via
Benzinga
Stocks Choppy As Bitcoin, Crypto Sell Off
September 19, 2022
Stocks are struggling for direction midday. The Dow Jones Industrial Average was last seen slightly below breakeven, while the S&P 500 Index and the Nasdaq Composite are back in the red.
Via
Talk Markets
Stocks That Hit 52-Week Lows On Monday
September 19, 2022
On Monday, 429 stocks made new 52-week lows.
Via
Benzinga
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session
September 19, 2022
Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74.
Via
Benzinga
How Is The Market Feeling About Syros Pharmaceuticals?
September 19, 2022
Syros Pharmaceuticals's (NASDAQ:SYRS) short percent of float has risen 5.3% since its last report. The company recently reported that it has 3.85 million shares sold short, which...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.